APVO (aptevotherapeutics.com) Net Profit
Aptevo Therapeutics (APVO) bases its development on the creation of targeted bispecific antibodies for oncology. The company's profit dynamics clearly illustrate this process, while the -0.03 metric indicates the status of the current result. Drug production is delegated to proven US contractors. However, a shortage of funds for testing and high competition create serious financial threats to the business.
Analytical breakdowns and data insights for company aptevotherapeutics.com (APVO)
- price and consensus price forecast:
- business market valuation indicators:
- book capitalization data:
- debt and solvency information:
Total Debt to Equity Ratio Aptevo Therapeutics|APVO - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Aptevo Therapeutics Inc.|APVO - Company Total Debt|Debts to Book Capitalization Aptevo Therapeutics Inc.|APVO - Company Long-Term Debt|Company Short-Term Indebtedness Aptevo Therapeutics|Immediate Liquidity aptevotherapeutics.com
- net income and valuation multiples indicators:
Summary company analysis:Aptevo Therapeutics
Aptevo Therapeutics (APVO) is developing immuno-oncology drugs within the stable North American region, which minimizes external trade and sanctions risks. By analyzing the company's current net income, an investor can observe the daily balance between operating expenses and revenues, allowing for an assessment of the real return on capital and the timely identification of abnormal spikes that may signal a potential asset freeze.
Main competitors
Net Income argenx BVBA|BNTX (BioNTech SE) - Net Profit|Net Profit Abivax Pharma|Net Income ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Final Profit|Net Profit IMVT (Immunovant Corp)|Net Financial Result Kiniksa Corp (KNSA)|GRFS - Company Net Income|adaptivebiotech.com (ADPT) - Net Income|Celldex Therapeutics, Inc. (CLDX) - Company Net Income|Net Income Aurinia Pharmaceuticals Inc|Net Income BCRX|Net Profit Vera Corp|Company Net Income Dianthus Therapeutics (DNTH)|pharvaris.com - Company Profit|Net Profit ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Company Net Income|Intrexon - Net Profit|PHAR - Net Profit|Nektar Therapeutics (NKTR) - Company Net Income|Profit After Tax UPB (upstreambio.com)|Net Income ZBIO|IMNM (Immunome Inc) - Profit After Payment of Taxes|Net Profit GOSS|KALV - Company Net Income|Septerna Inc - Net Income|pieris.com - Company Net Income|SVRA - Company Net Income|Company Net Income Rigel Pharma|ANAB (AnaptysBio Corp) - Net Income|Astria Corp - Final Profit|Net Income ENGN|RAPT (rapt.com) - Profit After Payment of Taxes|Net Profit JBIO|ACRS (Aclaris Therapeutics Inc.) - Final Profit|Net Profit KYTX (Kyverna)|Tiziana Life Sciences, Ltd. (TLSA) - Company Net Income|CABA - Company Net Income|Final Profit VTYX (ventyxbio.com)|THTX: Net Profit|Avalo Therapeutics, Inc. (AVTX) - Net Profit|Company Net Income Eledon|Agenus, Inc - Profit After Tax|Net Profit CLYM|ZURA - Company Net Income|aTyr Pharma - Net Income|Net Profit Adagene Inc ADAG|IMA: Net Income|Shattuck Labs, Inc. - Profit After Payment of Taxes|EQ: Net Profit|CNTB - Net Financial Result|IMUX (Immunic Therapeutics) - Net Profit|Net Income Atara Biotherapeutics Inc (ATRA)|Company Net Income InflaRx N.V. (IFRX)|Net Financial Result X4 Pharmaceuticals, Inc|Net Profit ACET (Adicet Bio, Inc.)|Net Profit Celularity Inc CELU|INMB - Company Net Income|Profit After Tax BRNS|KZR (Kezar Life Sciences, Inc) - Net Income|SABS (SAB Biotherapeutics Inc) - Company Net Income|Company Net Income Akari Therapeutics|Company Net Income Enlivex Therapeutics, Ltd. ENLV|Company Net Income Q32 Bio Inc. (QTTB)|GOVX: Profit After Tax|Net Profit EDSA (Edesa)|Final Profit IBIO|Carisma Tx - Net Profit|XTLB - Net Profit|boltbio.com (BOLT) - Company Net Income|HCW Biologics - Final Profit|Company Net Income AIM ImmunoTech|Net Income Aditxt Corp (ADTX)|Net Profit GRI|Net Profit xortx.com (XRTX)|Vyome Holdings - Net Income|Final Profit REVB|Indaptus - Net Profit|Net Financial Result BiondVax Pharmaceuticals SCNI|calcimedica.com (CALI) - Company Net Income|Net Income Affimed N.V.|Company Net Income Allakos Inc|Net Income HOOKIPA (HOOK)|Net Income IGMS (IGM Biosciences, Inc.)|Net Profit iTeos Pharma (ITOS)|Company Net Income Ocean Biomedical, Inc. OCEA|TCBP: Company Profit|Third Harmonic Bio, Inc. - Net Profit